# US 6,726,894 B1 · Transport vehicles for macromolecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,894 B1
- Document ID: US6726894B1
- Status: Granted
- Kind: B1
- Application number: 09/221,056
- Filed: 1998-12-28
- Granted: 2004-04-27
- Earliest claimed: 1995-07-25
- Assignees: Synvolux IP B.V.
- Inventors: Jan Bernard Frederik Nicolaas Engberts; Anno Wagenaar; Dirk Hoekstra; Irene Van Der Woude; Marcel Herman Jozef Ruiters
- Web page: https://patentgrep.com/patent/US6726894B1

## CPC

- C07D 213/20: Quaternary compounds thereof
- C07D 213/80: in position 3
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to new compounds with the general formula I for use as a tool to introduce macromolecules into cells. The invention further relates to compositions for introducing macromolecules into cells, comprising vesicles formed by at least one compound in a solvent. The macromolecule can be incorporated in the vesicles and/or bound to the vesicles or another aggregate of the new compounds. In a preferred embodiment at least one targeting molecule, for instance a (labelled) antibody, may further be attached to the vesicles

## Claims

### Claim 1

Compounds with the general formula I
in which:
R1 is a (a) branched or linear (C1-C5)alkyl, or
(b) branched or linear ((C1-C5)alkyl)aryl, or
(c) branched or linear ((C1-C5)alkyl)N+(CH3)3, or
(d) branched or linear ((C1-C5)alkyl)2R2,R3,R4-pyridinium in compliance with formula I
X− is a halide counter ion chosen from Cl−, I− or Br−, and in which
R3 is hydrogen and R2 and R4 are identical or different and are selected from the group consisting of branched or linear: (C10-C20)alkyl, mono- or polyunsaturated (C10-C20)alkenyl, (C═O)—O—(C10-C20)alkyl, O—(C═O)—(C10-C20)alkyl, and ((C10-C20)alkyl)aryl, or
R2 and R4 are hydrogen and R3 is CHR5R′5 in which R5 and R′5 are identical or different and are selected from the group consisting of branched or linear: (C10-C20)alkyl, mono- or polyunsaturated (C10-C20)alkenyl, (C═O)—O—(C10-C20)alkyl, O—(C═O)—(C10-C20)alkyl, and ((C10-C20)alkyl)aryl,
wherein disclaimed are the compounds with the general formula I in which R1 is CH3, R2 and R4 are hydrogen, R3 is (C16H33)2CH and X− is all mentioned counter ions (Cl−, I−, Br−) and disclaimed are the compounds in which R1 is CH3, R2 and R4 are C16H33—O—(C═O), R3 is hydrogen and X− is all mentioned counter ions (Cl−, I−, Br−).

### Claim 2 (depends on 1)

Compounds according to claim 1, characterized in that R1 is CH3, R2 and R4 are hydrogen, R3 is (C18H37)2CH and X is Cl−, Br−, I−.

### Claim 3 (depends on 1)

Compounds according to claim 1, characterized in that R1 is (CH2)4—N+(CH3)3, R2 and R4 are hydrogen, R3 is (C18H35)2CH and X is Cl−, Br−, I−.

### Claim 4 (depends on 1)

Compounds according to claim 1, characterized in that R1 is CH3, R2 and R4 are C18H“—O—C(O), R3 is hydrogen and X is Cl−, Br−, I−.

### Claim 5 (depends on 1)

Compounds according to claim 1, characterized in that R1 is CH3, R3 is hydrogen, R2 and R4 are (C═O)—O—(C10-C20)alkyl, mono- or polyunsaturated (C═O)—O—(C10-C20)alkenyl or (C═O)—O—((C10-C20)alkyl)aryl, and X− is Cl−, Br−, or I−.

### Claim 6 (depends on 1)

Compounds according to claim 1, characterized in that R1 is CH3, R3 is hydrogen, R2 and R4 are not identical and each represents a group with the formula (C═O)—O—(C10-C20)alkyl, mono- or polyunsaturated (C═O)—O—(C10-C20)alkenyl, or (C═O)—O—((C10-C20)alkyl)aryl, and X− is Cl−, Br−, or I−.

### Claim 7 (depends on 1)

Compounds according to claim 1, characterized in that R1 is CH3, R2 and R4 are hydrogen, R3=CHR5R′5, and in which R5 and R′5 are identical or different and are selected from the group consisting of (C═O)—O—(C10-C20)alkyl, mono- or polyunsaturated (C═O)—O—(C10-C20)alkenyl, or (C═O)—O—((C10-C20)alkyl)aryl, and X− is Cl−, Br−, or I−.

### Claim 8 (depends on 7)

Compounds according to claim 7, characterized in that R5 and R′5 are (C═O)—O—C16H33.

### Claim 9 (depends on 1)

Compounds according to claim 1, characterized in that R1 is (CH2)n—C6H5, in which n=3-6, R2 and R4 are hydrogen, R3=CHR5R′5, R5 and R′5 are identical or different and are selected from the group consisting of branched or linear: (C10-C20)alkyl and mono- or polyunsaturated (C10-C20)alkenyl; and X− is Cl−, Br− or I−.

### Claim 10 (depends on 9)

Compounds according to claim 9, characterized in that R1 is (CH2)3—C6H5, R2 and R4 are hydrogen, R5 and R′5 are n-C12H25 and X− is Cl−, Br− or I−.

### Claim 11 (depends on 1)

Compounds according to claim 1, characterized in that R1 is ((CH2)4)R2,R3,R4-pyridinium, in which R2 and R4 are hydrogen, R3 is (C18H35)2CH, and X− is Cl−, Br−, or I−.

### Claim 12 (depends on 1)

A composition to introduce macromolecules into cells, comprising a mixture of a compound according to claim 1 and at least one macromolecule.

### Claim 13 (depends on 12)

The composition according to claim 12, further comprising at least one targeting molecule.

### Claim 14 (depends on 13)

The composition according to claim 13, wherein the targeting molecule is an antibody.

### Claim 15 (depends on 14)

The composition according to claim 14, wherein the antibody is radioactively labeled or labeled with streptavidine.

### Claim 16 (depends on 12)

The composition according to claim 12, wherein the macromolecule is a nucleic acid.

### Claim 17 (depends on 1)

A method of introducing macromolecules into cells comprising:
a. forming a mixture comprising a compound according to claim 1 and at least one macromolecule; and
b. contacting cells with said mixture.
